Cutaneous polyarteritis nodosa resulting from a paclitaxel-eluting balloon angioplasty

Montgomery, Allison; Kushner, Jeffrey; Altman, David A.

doi:10.1016/j.jdcr.2017.09.024

Cited by 6 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There has been one report of cutaneous effects lingering beyond 16 weeks after intervention. 16 Similar to others, our patient exhibited signs/symptoms shortly after intervention but went on to make a full recovery by 12 weeks postoperatively. Unlike others, our patient showed extensive diffuse cutaneous lesions extending beyond a single arterial distribution in the postoperative period that can understandably be worrisome for clinician and patients.…”

Section: Discussionsupporting

confidence: 86%

Diffuse Cutaneous Manifestations after Drug-Coated Balloon Angioplasty

Chen

Lee

Sabat

et al. 2020

Annals of Vascular Surgery

View full text Add to dashboard Cite

We present here a case of an uncommon cutaneous manifestation after paclitaxel-coated balloon angioplasty. In this case, the patient underwent drug-coated balloon angioplasty for stenosis of a prior vein bypass graft. The patient subsequently developed extensive cutaneous lesions not confined to a single arterial distribution. This case represents a rare complication related to paclitaxel-eluting balloons and provides a cautionary tale as well as clinical acumen for providers in using such devices in their practice.

show abstract

Section: Discussionsupporting

confidence: 86%

Diffuse Cutaneous Manifestations after Drug-Coated Balloon Angioplasty

Chen

Lee

Sabat

et al. 2020

Annals of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…Of those 4 reports, 3 were biopsied and revealed panniculitis, polyarteritis nodosa, and small-vessel vasculitis, respectively. 2 , 3 , 4 All 3 cases were treated with systemic steroids with complete resolution within 3-4 months. In the case of polyarteritis nodosa, the patient developed symptoms approximately 1 month after the procedure, suggesting a more delayed immune-related phenomenon in contrast to the more acute-onset manifestation in our patient, which was likely secondary to direct embolic effects.…”

Section: Discussionmentioning

confidence: 99%